ATE528408T1 - Selektivitätsprofilerstellung von mit pi3k wechselwirkenden molekülen gegen mehrere ziele - Google Patents
Selektivitätsprofilerstellung von mit pi3k wechselwirkenden molekülen gegen mehrere zieleInfo
- Publication number
- ATE528408T1 ATE528408T1 AT09709335T AT09709335T ATE528408T1 AT E528408 T1 ATE528408 T1 AT E528408T1 AT 09709335 T AT09709335 T AT 09709335T AT 09709335 T AT09709335 T AT 09709335T AT E528408 T1 ATE528408 T1 AT E528408T1
- Authority
- AT
- Austria
- Prior art keywords
- multiple target
- against multiple
- interacting molecules
- molecules against
- pi3k
- Prior art date
Links
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 title abstract 3
- 108091007960 PI3Ks Proteins 0.000 title abstract 3
- WYKHSBAVLOPISI-UHFFFAOYSA-N 2-phenyl-1,3-thiazole Chemical compound C1=CSC(C=2C=CC=CC=2)=N1 WYKHSBAVLOPISI-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
- G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Catalysts (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08002053 | 2008-02-04 | ||
| PCT/EP2009/000692 WO2009098021A1 (en) | 2008-02-04 | 2009-02-03 | Selectivity profiling of pi3k interacting molecules against multiple targets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE528408T1 true ATE528408T1 (de) | 2011-10-15 |
Family
ID=39561994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09709335T ATE528408T1 (de) | 2008-02-04 | 2009-02-03 | Selektivitätsprofilerstellung von mit pi3k wechselwirkenden molekülen gegen mehrere ziele |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110111972A1 (de) |
| EP (2) | EP2245181B1 (de) |
| JP (1) | JP2011514965A (de) |
| CN (1) | CN101965408B (de) |
| AT (1) | ATE528408T1 (de) |
| AU (1) | AU2009211845A1 (de) |
| CA (1) | CA2713276A1 (de) |
| DK (1) | DK2245181T3 (de) |
| ES (1) | ES2375541T3 (de) |
| WO (1) | WO2009098021A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1887359T3 (da) | 2006-08-03 | 2009-03-02 | Cellzome Ag | Fremgangsmåde til identifikation af PI3K-interagerende molekyler og til rensning af PI3K |
| EP2406258B1 (de) | 2009-03-13 | 2014-12-03 | Cellzome Limited | Pyrimidin-derivate als mtor-hemmer |
| EP2542536B1 (de) | 2010-03-04 | 2015-01-21 | Cellzome Limited | Morpholinsubstituierte Harnstoff-Derivate als mTOR-Hemmer |
| US20130210030A1 (en) | 2010-07-19 | 2013-08-15 | Cellzome Ag | In vivo method for the evaluation of a compound-target interaction |
| US20140163023A1 (en) | 2011-04-04 | 2014-06-12 | Cellzome Limited | Dihydropyrrolo pyrimidine derivatives as mtor inhibitors |
| EP2758379B1 (de) | 2011-09-21 | 2016-10-19 | Cellzome Limited | Harnstoff- und Carbamatderivate des 2-Morpholino-1,3,5-Triazins als mTOR Inhibitoren zur Behandlung von immunologischen oder proliferative Erkrankungen |
| AU2012320465B2 (en) | 2011-10-07 | 2016-03-03 | Cellzome Limited | Morpholino substituted bicyclic pyrimidine urea or carbamate derivatives as mTOR inhibitors |
| CN102977063A (zh) * | 2012-11-26 | 2013-03-20 | 盛世泰科生物医药技术(苏州)有限公司 | 一种2-吗啡啉-8-苯基-4-苯并吡喃-4-酮的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5525503A (en) * | 1993-09-28 | 1996-06-11 | Dana-Farber Cancer Institute, Inc. | Signal transduction via CD28 |
| US20030194749A1 (en) * | 2002-02-15 | 2003-10-16 | Wandless Thomas J. | Wortmannin derivatives as probes of cellular proteins and processes |
| AR038703A1 (es) | 2002-02-28 | 2005-01-26 | Novartis Ag | Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3 |
| SE0402735D0 (sv) * | 2004-11-09 | 2004-11-09 | Astrazeneca Ab | Novel compounds |
| EP1734367A1 (de) * | 2005-06-14 | 2006-12-20 | Cellzome Ag | Verfahren zum Auffinden von neuen Verbindungen, die mit einem Enzym in Wechselwirkung treten |
| AU2006259153B2 (en) | 2005-06-14 | 2012-04-12 | Cellzome Gmbh | Process for the identification of novel enzyme interacting compounds |
| CN101300047A (zh) * | 2005-09-07 | 2008-11-05 | 雪兰诺实验室有限公司 | Pi3k抑制剂用于子宫内膜异位症的治疗 |
| DK1866433T3 (da) * | 2006-03-14 | 2009-08-17 | Cellzome Ag | Fremgangsmåde til identifikation af LRRK-2interagerende molekyler og til rensning af LRRK2 |
| DK1887359T3 (da) | 2006-08-03 | 2009-03-02 | Cellzome Ag | Fremgangsmåde til identifikation af PI3K-interagerende molekyler og til rensning af PI3K |
-
2009
- 2009-02-03 US US12/866,000 patent/US20110111972A1/en not_active Abandoned
- 2009-02-03 WO PCT/EP2009/000692 patent/WO2009098021A1/en not_active Ceased
- 2009-02-03 JP JP2010544648A patent/JP2011514965A/ja active Pending
- 2009-02-03 AT AT09709335T patent/ATE528408T1/de active
- 2009-02-03 CA CA2713276A patent/CA2713276A1/en not_active Abandoned
- 2009-02-03 DK DK09709335.5T patent/DK2245181T3/da active
- 2009-02-03 EP EP09709335A patent/EP2245181B1/de not_active Not-in-force
- 2009-02-03 ES ES09709335T patent/ES2375541T3/es active Active
- 2009-02-03 EP EP11008204A patent/EP2410062A1/de not_active Withdrawn
- 2009-02-03 AU AU2009211845A patent/AU2009211845A1/en not_active Abandoned
- 2009-02-03 CN CN2009801077436A patent/CN101965408B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101965408A (zh) | 2011-02-02 |
| DK2245181T3 (da) | 2012-02-06 |
| EP2245181B1 (de) | 2011-10-12 |
| CN101965408B (zh) | 2013-08-28 |
| EP2245181A1 (de) | 2010-11-03 |
| ES2375541T3 (es) | 2012-03-01 |
| EP2410062A1 (de) | 2012-01-25 |
| AU2009211845A1 (en) | 2009-08-13 |
| JP2011514965A (ja) | 2011-05-12 |
| US20110111972A1 (en) | 2011-05-12 |
| HK1144705A1 (en) | 2011-03-04 |
| CA2713276A1 (en) | 2009-08-13 |
| WO2009098021A1 (en) | 2009-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE528408T1 (de) | Selektivitätsprofilerstellung von mit pi3k wechselwirkenden molekülen gegen mehrere ziele | |
| EA201170124A1 (ru) | Полихромные вещества и их применение | |
| CY2017044I2 (el) | Αντισωματα εναντι cd38 για τη θεραπεια του πολλαπλου μυελωματος | |
| JOP20180102B1 (ar) | مركب صيدلاني | |
| UA110338C2 (xx) | Хімічні сполуки | |
| EA200970402A1 (ru) | Триазолопиридазиновые модуляторы протеинкиназ | |
| BRPI1009637A2 (pt) | composto, composição e uso de um composto | |
| LT2889043T (lt) | Sintetiniai tarpiniai junginiai oligosacharido-baltymo konjugatų gamybai | |
| SMP201100019B (it) | Composti organici | |
| BR112013026324A2 (pt) | compostos de benzeno substituídos com arila ou heteroarila | |
| PL2342196T3 (pl) | Związki pirazolowe do zwalczania szkodników będących bezkręgowcami | |
| EA201500173A1 (ru) | Фунгицидные композиции | |
| EA200901388A1 (ru) | Повышение продуктивности растений путем комбинирования химических веществ с трансгенными модификациями | |
| CY1111793T1 (el) | Μυκητοκτονες συνθεσεις | |
| CO6640320A2 (es) | Composición de control de fitoenfermedades y metodo de control de fitoenfermedades | |
| BR112015018509A2 (pt) | compostos de imidazo piridina | |
| EA201101669A1 (ru) | Новая соль базедоксифена | |
| UY33196A (es) | Antidotos de anticoagulantes | |
| EA200702363A1 (ru) | Новые лиганды гистамина h-рецептора и их терапевтические применения | |
| ATE511845T1 (de) | Verwendung von isothicyanat-derviaten als myelom- bekämpfende wirkstoffe | |
| EA201590979A1 (ru) | Способы и промежуточные химические соединения для получения фармацевтических средств | |
| UY32074A (es) | Compuestos de pirrol | |
| ATE539054T1 (de) | Verfahren zur herstellung von dihydropyrrolderivaten als zwischenprodukte | |
| EA201101152A1 (ru) | Лиофилизированный дабигатран | |
| CR11463A (es) | Compuestos de piridilmetil-sulfonamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2245181 Country of ref document: EP |